Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cyclophosphamide, methotrexate, and fluorouracil: Still the gold standard?
    Journal Article

    Hudis, C. A.
    Journal of Clinical Oncology (1996)

    Fulltext@MSK | Save
  • Management of advanced breast cancer: Patient needs, challenges and new treatment options: Introduction
    Journal Article

    Norton, L.
    Anti-Cancer Drugs (1996)

    Fulltext@MSK | Save
  • Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
    Journal Article

    Schneider, C.; Sepp-Lorenzino, L.; Nimmesgern, E.; Ouerfelli, O.; Danishefsky, S.; Rosen, N.; Hartl, F. U.
    Proceedings of the National Academy of Sciences of the United States of America (1996)

    Fulltext@MSK | Save
  • Targeted therapy for prostate cancer: The Memorial Sloan-Kettering Cancer Center approach
    Conference Paper

    Slovin, S. F.; Livingston, P. O.; Rosen, N.; Sepp-Lorenzino, L.; Kelly, W. K.; Mendelsohn, J.; Scher, H. I.
    Elsevier Inc. (1996)

    Fulltext@MSK | Save
  • Implications of a fractal model of neoplasia for the detection of microscopic breast cancer
    Journal Article

    Norton, L.
    Breast (1996)

    Fulltext@MSK | Save
  • Farnesyltransferase inhibitors and anti-Ras therapy
    Conference Paper

    Gibbs, J. B.; Kohl, N. E.; Koblan, K. S.; Omer, C. A.; Sepp-Lorenzino, L.; Rosen, N.; Anthony, N. J.; Conner, M. W.; deSolms, S. J.; Williams, T. M.; more...
    Springer (1996)

    Fulltext@MSK | Save
  • Chemotherapy for advanced breast cancer: A current perspective
    Journal Article

    Seidman, A. D.
    Seminars in Oncology (1996)

    Fulltext@MSK | Save
  • Adjuvant drug therapy for operable breast cancer
    Journal Article

    Hudis, C. A.; Norton, L.
    Seminars in Oncology (1996)

    Fulltext@MSK | Save
  • An exploratory study of frequent pain measurement in a cancer clinical trial
    Journal Article

    Ingham, J.; Seidman, A.; Yao, T. J.; Lepore, J.; Portenoy, R.
    Quality of Life Research (1996)

    Fulltext@MSK | Save
  • Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ
    Journal Article

    Bromberg, J. F.; Horvath, C. M.; Wen, Z.; Schreiber, R. D.; Darnell, J. E. Jr
    Proceedings of the National Academy of Sciences of the United States of America (1996)

    Fulltext@MSK | Save